login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 

Serotonin levels can be detected and measured through an innovative device called WINCS


Monday, 07 Feb 2011 14:31

Mayo Clinic researchers have concluded that, through deep brain stimulation, a Wireless Instantaneous Neurotransmitter Concentration System (WINCS) can detect and measure serotonin levels in the brain. The findings suggest that in the future such measurements of serotonin may help establish a therapeutic mechanism of deep brain stimulation for psychiatric disease. This study was published in the September 2010 issue of the Journal of Neurosurgery.


Serotonin is a neurotransmitter in the brain that is thought to play a key role in controlling depression, the second most disabling condition in the developed world, with lifetime prevalence in the United States of 17%. Using deep brain stimulation, neurosurgeons can help patients with essential tremor, Parkinson’s disease, movement disorders, and now, based on this study, psychiatric disorders.


“In a previous study, in order to better understand the mechanism of deep brain stimulation, we created WINCS, a new device that successfully measured such neurotransmitter levels as dopamine and norepinephrine on a second-by-second basis,” said Kendall Lee, neurosurgeon at Mayo Clinic. “In this experiment, we wanted to try to measure serotonin, which is very important in the mechanism of depression and its treatment. This study shows that WINCS can measure serotonin with a technology called fast-scan cyclic voltammetry, which is an electrochemical method of being able to measure serotonin in real time in the living brain,” Kendall added.

Researchers collaborated with Mayo Clinic’s division of Engineering and Paul Garris, at Illinois State University, who helped design and test the WINCS device. “We were able to take the laboratory method of neurotransmitter detection and create a miniaturised, wireless, computer-controlled device that allowed the detection to occur in real time,” says Kevin Bennet, chair, Mayo Clinic’s division of Engineering “We took the technique of fast-scan cyclic voltammetry, created real-time control and reporting, and converted it into something that can be used in animals and humans.”

“Using this device, we can now do real-time serotonin measurement, so we are hopeful that in the near future we are able to use WINCS to measure serotonin in the human brain,”  said Lee “What is significant is that if we can measure serotonin, perhaps we can modulate it. This opens the door for even more exciting areas of medicine. By having technology such as WINCS, rather than just diagnosing or measuring neurotransmitters, you can use this as a therapeutic tool to more precisely regulate brain neurotransmitter levels.”




Add New Comment

Most popular


Next generation Medina coil system shows improvements in early human experience
Thursday, 26 Feb 2015
In early use of the Medina coil system, researchers have found the device to be a next generation coil that combines the familiar procedural safety and technique associated with conventional coils, ... Next generation Medina coil system shows improvements in early human experience

Better outcomes observed in MR CLEAN non-general anaesthesia subgroup in post-hoc analysis
Thursday, 02 Apr 2015
In a post-hoc analysis of the use of general anaesthesia in the MR CLEAN trial (Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands) ... Better outcomes observed in MR CLEAN non-general anaesthesia subgroup in post-hoc analysis

Cover device proves more effective than guide catheter in stroke model
Wednesday, 18 Mar 2015
In an in vitro stroke model comparison, the use of the Cover accessory device (Lazarus Effect) in conjunction with a stent retriever resulted in higher successful recanalisation rates, no embolic ... Cover device proves more effective than guide catheter in stroke model

Features


New day in acute ischaemic stroke therapy
Friday, 17 Apr 2015
The newest generation of trials for acute ischaemic stroke, including MR CLEAN, ESCAPE, EXTEND IA and SWIFT PRIME, appear to have ushered in a new era in stroke therapy. Now, Joseph Broderick (... New day in acute ischaemic stroke therapy

Flow diverter technology for intracranial aneurysms
Tuesday, 31 Mar 2015
Gabor Toth writes for NeuroNews about the flow diverters that are currently available and the ongoing clinical trials that could have the potential to extend the indications of flow diverter therapy ... Flow diverter technology for intracranial aneurysms

Profiles


Joseph Broderick
Wednesday, 07 Jan 2015
Joseph Broderick speaks to NeuroNews about the future of neurology and his research, in particular, ... Joseph Broderick

Vladimír Beneš Jr
Tuesday, 30 Sep 2014
Vladimír Beneš Jr is professor and chair at the First Medical School, Charles University, P... Vladimír Beneš Jr

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions